KRISTIN LINDMAN: Open Payments
NPI 1326660580 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 14 payments from 7 companies in 2025. Trend: 2023 $78 · 2024 $54 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $104 |
| Melinta Therapeutics, LLC | 3 | $67 |
| Aimmune Therapeutics, Inc. | 2 | $45 |
| Paratek Pharmaceuticals, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Insmed, Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: Rezzayo, NUZYRA, HYQVIA, EMBLAVEO, DALVANCE, SKYRIZI, ZENPEP, TEFLARO.
Industry payments across MI — which companies pay providers there.
